Duncan McHale
Direttore Tecnico/Scientifico/R&S presso EVELO BIOSCIENCES, INC.
Patrimonio netto: 781 $ in data 30/04/2024
Profilo
Duncan McHale is the founder of Weatherden Ltd.
(founded in 2017) and holds the title of Director.
He is currently a Director at Excite Ventures Ltd.
and holds the title of Chief Medical Officer at Evelo Biosciences, Inc. (since 2018) and Member-Supervisory Board at Evotec SE (since 2024).
Previously, he worked at UCB SA (2011-2017) as Head-Global Exploratory Development, Pfizer Ltd.
(1999-2008) as ED & Head-Translational Molecular Medicine, and AstraZeneca Pharmaceuticals LP (1999-2011) as Vice President & Head-Translational Sciences.
Dr. McHale obtained a doctorate degree from the University of Leeds in 1999 and an undergraduate degree from The University of Newcastle in 1991.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EVELO BIOSCIENCES, INC.
0.09% | 08/11/2023 | 16 984 ( 0.09% ) | 781 $ | 30/04/2024 |
Posizioni attive di Duncan McHale
| Società | Posizione | Inizio |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/02/2018 |
| EVOTEC SE | Direttore/Membro del Consiglio | 10/06/2024 |
Weatherden Ltd.
 Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017. | Fondatore | 01/04/2017 |
| Excite Ventures Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Duncan McHale
| Società | Posizione | Fine |
|---|---|---|
| UCB | Corporate Officer/Principal | 01/05/2017 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | 01/08/2011 |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2008 |
Formazione di Duncan McHale
| The University of Newcastle | Undergraduate Degree |
| University of Leeds | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| EVELO BIOSCIENCES, INC. | Health Technology |
| UCB | Health Technology |
| EVOTEC SE | Health Technology |
| Aziende private | 4 |
|---|---|
Weatherden Ltd.
Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017. | Health Technology |
| Excite Ventures Ltd. | |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Duncan McHale
